Regranex

Active Ingredient(s): Becaplermin, rh-PDGF
FDA Approved: * December 16, 1997
Pharm Company: * OMJ PHARMACEUTICALS
Category: Ulcer

Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good wound care for the treatment of lower extremity diabetic neuropathic ulcers.[1] It is also known as "platelet-derived growth factor BB".[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 See also 5 References 6 External links Medical uses The drug is used for the treatment of diabet... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Regranex 100 ug/g Topical Gel
NDC: 0064-0810
Labeler:
Healthpoint, Ltd
Regranex 100 ug/g Topical Gel
NDC: 50484-810
Labeler:
Smith & Nephew, Inc.

Popular Topics

Regranex Gel

becaplevmin...